Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Top ten contact dermatitis allergens identified in Mayo Clinic study

06.03.2006


Research also confirms utility of patch testing to discover allergens and finds patients satisfied with testing, yet they recall only half of their allergens



A new Mayo Clinic study reveals the most common causes of allergic contact dermatitis, a skin inflammation resulting in swollen, reddened and itchy skin due to direct contact with an allergen. Topping the list were:

  • Nickel (nickel sulfate hexahydrate) -- metal frequently encountered in jewelry and clasps or buttons on clothing
  • Gold (gold sodium thiosulfate) -- precious metal often found in jewelry
  • Balsam of Peru (myroxylon pereirae) -- a fragrance used in perfumes and skin lotions, derived from tree resin
  • Thimerosal -- a mercury compound used in local antiseptics and in vaccines
    Neomycin sulfate -- a topical antibiotic common in first aid creams and ointments, also found occasionally in cosmetics, deodorant, soap and pet food
  • Fragrance mix -- a group of the eight most common fragrance allergens found in foods, cosmetic products, insecticides, antiseptics, soaps, perfumes and dental products
  • Formaldehyde -- a preservative with multiple uses, e.g., in paper products, paints, medications, household cleaners, cosmetic products and fabric finishes
  • Cobalt chloride -- metal found in medical products; hair dye; antiperspirant; objects plated in metal such as snaps, buttons or tools; and in cobalt blue pigment
  • Bacitracin -- a topical antibiotic
  • Quaternium 15 -- preservative found in cosmetic products such as self-tanners, shampoo, nail polish and sunscreen or in industrial products such as polishes, paints and waxes

This study, to be presented Monday at the American Academy of Dermatology annual meeting in San Francisco, confirmed that patch testing with a standard contact dermatitis series of substances is useful for identifying common contact allergens. Patch testing is conducted by placing potential allergens covered with patches on patients’ backs for two days and then observing which substances cause skin inflammation. The study confirmed previous findings by the North American Contact Dermatitis Group.

The researchers examined contact dermatitis testing results from 3,854 patients over a five-year period between Jan. 1, 2001 and Dec. 31, 2005. The patients were tested with an average of 69 allergens. Of these patients, 2,663 (69 percent) had at least one positive reaction, and 1,933 (50 percent) had two or more positive reactions.



Results of two other Mayo Clinic studies on contact dermatitis will be presented at the American Contact Dermatitis Society meeting, which immediately precedes the American Academy of Dermatology meeting. In the first study, researchers mailed a written survey to 1,458 recently tested contact dermatitis patients. The survey found that, overall, patients were satisfied with the contact dermatitis patch testing process and with subsequent improvement of their skin conditions. More than 75 percent of respondents said they were at least "somewhat satisfied" with the overall testing and treatment process, and over one-half reported they were "very satisfied." Nearly 60 percent indicated improvement in their skin conditions since the patch testing.

In the second study to be presented at the American Contact Dermatitis Society meeting, researchers included a write-in question with the aforementioned survey mailing. The survey found patients could recall only 50.6 percent of the allergens for which they tested positive an average of 13.4 months after patch testing. The researchers indicate these findings point to the ongoing need for education to remind patients of their allergens and reinforce the importance of avoiding them.

Contact dermatitis is common among all age groups and can cause minor annoyance to more severe handicaps, according to Mark Davis, M.D., Mayo Clinic dermatologist and lead study researcher. "Patients with contact dermatitis can get a very itchy rash from head to toe, or in a confined area," he says. "If it’s on the hands and feet it can be disabling, and patients at times can’t do their jobs."

Allergen avoidance is the chief treatment for contact dermatitis, according to Dr. Davis, though at times corticosteroid creams are used to treat rashes. He notes, however, that 3 percent of patients with contact dermatitis are allergic to the topical steroids that would alleviate their symptoms.

Lisa Lucier | EurekAlert!
Further information:
http://www.mayo.edu

More articles from Studies and Analyses:

nachricht Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT

nachricht Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>